3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
230
Lymphoma
229
Lymphoma, Non-Hodgkin
198
Leukemia, Lymphocytic, Chronic, B-Cell
180
Lymphoma, Large B-Cell, Diffuse
173
Lymphoma, Follicular
170
Lymphoma, B-Cell
111
Lymphoma, Mantle-Cell
105
Hodgkin Disease
102
Recurrence
97
Leukemia, Myeloid, Acute
95
Multiple Myeloma
91
Burkitt Lymphoma
89
Leukemia
78
Neoplasms
67
Hematologic Neoplasms
61
Lymphoma, B-Cell, Marginal Zone
58
Myelodysplastic Syndromes
54
Waldenstrom Macroglobulinemia
42
Lymphoma, T-Cell
42
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
38
Lymphoma, T-Cell, Peripheral
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Biphenotypic, Acute
29
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28
Leukemia, B-Cell
27
Lymphoma, Large-Cell, Anaplastic
26
Mycosis Fungoides
25
Sarcoma
24
Lymphoproliferative Disorders
21
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraparesis, Tropical Spastic
×
Lymphoid
×
90 days
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled